Immunity 54 , 17451757.e7 (2021)
For most patients, standard-dose semaglutide or tirzepatide is more likely to produce faster and more noticeable weight loss because the dose strategy is designed to reach stronger appetite-suppressing levels over time
At least half people taking the drug have reported nausea as a side effect
Preclinical studies in accelerated mouse models of diet-induced steatohepatitis have demonstrated that retatrutide improves steatohepatitis through mechanisms involving enhanced hepatic fat oxidation, reduced lipogenesis, decreased inflammation, and attenuation of fibrosis markers, supporting the rationale for clinical development in MASH [33]
The average fasting glucose of these participants, which was 105mg/dL significantly over the prediabetes cutoff of 100mg/dL
No market authorization in any jurisdiction